Entries by san1Admn

40 years of German biotechnology – a look back and ahead

In his latest article on transkript.de, Dr. Michael H. Thiel takes an exciting look back at the development of German biotechnology – and at the same time offers an optimistic outlook for the coming years. From the first start-ups in the 1980s to the dynamic start-up scene of the 1990s and today’s global competitiveness, it […]

More than 100 times the sensitivity: SANEMUS supports disruptive LFA technology

SANEMUS is pleased to support a promising start-up in its search for investors. The start-up is developing a groundbreaking platform technology that serves as a high-precision signal amplifier. The goal is to increase the sensitivity of lateral flow assays (LFAs) – known from rapid tests – by more than 100 times. This technology opens up […]

Ophthalmology project update

The ophthalmology project we are supporting is developing positively. The market entry strategy for Europe is currently being developed. If you are interested in the project or an investment, please contact us.

System to improve near vision for patients with presbyopia

Our team is currently supporting an American ophthalmology start-up in its search for capital. The startup is developing a unique system that improves near vision for patients with presbyopia. If you are interested in investing, we look forward to hearing from you.

Therapy for the treatment of fungal infections of the nails

Our team is supporting a German start-up in its search for co-development partners. The start-up is developing a novel, patent-protected therapy for the treatment of fungal infections of the nails. If you are interested in further information, please do not hesitate to contact us.

Algorithms in the field of cardiovascular diagnostics

SANEMUS supports Medtech Startup, which focuses on innovative biosignal analysis and intelligent medical algorithms in the field of cardiovascular diagnostics, in the search for investors. If you are interested in the project, we look forward to hearing from you.

German biotechnology start-ups 2020 – status and perspectives

In the article “German Biotechnology Start-ups 2020 – Status and Perspectives” by Dr. Michael Thiel, the status of German biotechnology in 2020 is presented on the one hand, and on the other hand the article aims to provide food for thought on what should change in the future to make Germany more attractive as a […]